Epidermal growth factor +61 G/A polymorphism and the risk of hepatocellular carcinoma in a Chinese population

Genetic Testing and Molecular Biomarkers

Volumn 15, Issue 4, 2011, Pages 251-255

  Chen, Kefei ^a   Wei, Yonggang ^a   Yang, Hanteng ^b   Li, Bo ^a  

^a SICHUAN UNIVERSITY   (China)

^b Wuwei Tumor Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR;

ADULT; ALLELE; ARTICLE; CHINESE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENOTYPE; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROTEIN POLYMORPHISM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CHINA; EPIDERMAL GROWTH FACTOR; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS;

HEPATITIS B VIRUS;

EID: 79953079457     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2010.0208     Document Type: Article

References (45)

1. Akkiz H, Sumbul AT, Bayram S, et al. (2010) MDM2 promoter polymorphism is associated with increased susceptibility to hepatocellular carcinoma in Turkish population. Cancer Epidemiol 34:448-452.
2. Araujo AP, Ribeiro R, Pereira D, et al. (2009a) Ovarian cancer and genetic susceptibility: association of A61G polymorphism in the EGF gene. Exp Biol Med (Maywood) 234:241-245.
3. Araujo AP, Ribeiro R, Pinto D, et al. (2009b) Epidermal growth factor genetic variation, breast cancer risk, and waiting time to onset of disease. DNA Cell Biol 28:265-269.
4. Asim M, Khan LA, Husain SA, et al. (2010) Genetic polymorphism of glutathione S transferases M1 and T1 in Indian patients with hepatocellular carcinoma. Dis Markers 28:369-376.
5. Bacaksiz A, Sahin FI, Bilezikci B, et al. (2008) Determination of HER-2/Neu status in hepatocellular carcinoma cases. Genet Test 12:211-214. (Pubitemid 351860439)
6. Ben-Ari Z, Mor E, Papo O, et al. (2003) Cytokine gene polymorphisms in patients infected with hepatitis B virus. Am J Gastroenterol 98:144-150. (Pubitemid 36135183)
7. Bhowmick DA, Zhuang Z, Wait SD, et al. (2004) A functional polymorphism in the EGF gene is found with increased frequency in glioblastoma multiforme patients and is associated with more aggressive disease. Cancer Res 64:1220-1223. (Pubitemid 38235584)
8. Blanc P, Etienne H, Daujat M, et al. (1992) Mitotic responsiveness of cultured adult human hepatocytes to epidermal growth factor, transforming growth factor alpha, and human serum. Gastroenterology 102:1340-1350.
9. Carpenter G, Cohen S (1979) Epidermal growth factor. Annu Rev Biochem 48:193-216. (Pubitemid 10191090)
10. Chen YL, Tseng HS, Kuo WH, et al. (2010) Glutathione S-Transferase P1 (GSTP1) gene polymorphism increases agerelated susceptibility to hepatocellular carcinoma. BMC Med Genet 11:46.
11. Cohen S (1962) Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the newborn animal. J Biol Chem 237:1555-1562.
12. de la Coste A, Romagnolo B, Billuart P, et al. (1998) Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA 95:8847-8851. (Pubitemid 28350577)
13. Fisher DA, Lakshmanan J (1990) Metabolism and effects of epidermal growth factor and related growth factors in mammals. Endocr Rev 11:418-442. (Pubitemid 20261694)
14. Gu X, Qi P, Zhou F, et al. (2010) An intronic polymorphism in the corticotropin-releasing hormone receptor 2 gene increases susceptibility to HBV-related hepatocellular carcinoma in Chinese population. Hum Genet 127:75-81.
15. Hamai Y, Matsumura S, Matsusaki K, et al. (2005) A single nucleotide polymorphism in the 50 untranslated region of the EGF gene is associated with occurrence and malignant progression of gastric cancer. Pathobiology 72:133-138. (Pubitemid 40674996)
16. Heneghan MA, Johnson PJ, Clare M, et al. (2003) Frequency and nature of cytokine gene polymorphisms in hepatocellular carcinoma in Hong Kong Chinese. Int J Gastrointest Cancer 34:19-26. (Pubitemid 38962757)
17. Hoffmann B, Piasecki A, Paul D (1989) Proliferation of fetal rat hepatocytes in response to growth factors and hormones in primary culture. J Cell Physiol 139:654-662. (Pubitemid 19167841)
18. Hsiao PC, Chen MK, Su SC, et al. (2010) Hypoxia inducible factor-1alpha gene polymorphism G1790A and its interaction with tobacco and alcohol consumptions increase susceptibility to hepatocellular carcinoma. J Surg Oncol 102:163-169.
19. Hu L, Liu J, Chen X, et al. (2010) CTLA-4 gene polymorphism +49 A/G contributes to genetic susceptibility to two infectionrelated cancers-hepatocellular carcinoma and cervical cancer. Hum Immunol 71:888-891.
20. Jemal A, Siegel R, Ward E, et al. (2008) Cancer statistics, 2008. CA Cancer J Clin 58:71-96. (Pubitemid 351521864)
21. Jin G, Miao R, Deng Y, et al. (2007) Variant genotypes and haplotypes of the epidermal growth factor gene promoter are associated with a decreased risk of gastric cancer in a high-risk Chinese population. Cancer Sci 98:864-868. (Pubitemid 46691824)
22. Jorissen RN, Walker F, Pouliot N, et al. (2003) Epidermal growth factor receptor: mechanisms of activation and signalling. Exp Cell Res 284:31-53. (Pubitemid 36331965)
23. Kang HG, Choi JE, Lee WK, et al. (2007a) +61A>G polymorphism in the EGF gene does not increase the risk of lung cancer. Respirology 12:902-905. (Pubitemid 350045717)
24. Kang S, Kim JW, Park NH, et al. (2007b) Epidermal growth factor 61A/G polymorphism and uterine cervical cancer. Int J Gynecol Cancer 17:492-496. (Pubitemid 46426784)
25. Kato N, Ji G, Wang Y, et al. (2005) Large-scale search of single nucleotide polymorphisms for hepatocellular carcinoma susceptibility genes in patients with hepatitis C. Hepatology 42:846-853. (Pubitemid 41401122)
26. Kim YJ, Lee HS (2005) Single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic hepatitis B virus infection. Intervirology 48:10-15. (Pubitemid 40529205)
27. Kiran M, Saxena R, Chawla YK, et al. (2009) Polymorphism of DNA repair gene XRCC1 and hepatitis-related hepatocellular carcinoma risk in Indian population. Mol Cell Biochem 327:7-13.
28. Lanuti M, Liu G, Goodwin JM, et al. (2008) A functional epidermal growth factor (EGF) polymorphism, EGF serum levels, and esophageal adenocarcinoma risk and outcome. Clin Cancer Res 14:3216-3222.
29. Laurence DJ, Gusterson BA (1990) The epidermal growth factor. A review of structural and functional relationships in the normal organism and in cancer cells. Tumour Biol 11:229-261. (Pubitemid 20292244)
30. Li Y, Xie Q, Lu F, et al. (2010) Association between epidermal growth factor 61A/G polymorphism and hepatocellular carcinoma susceptibility in Chinese patients. Liver Int 30:112-118.
31. Lim YJ, Kim JW, Song JY, et al. (2005) Epidermal growth factor gene polymorphism is different between schizophrenia and lung cancer patients in Korean population. Neurosci Lett 374:157-160. (Pubitemid 40128286)
32. Limaye PB, Bowen WC, Orr AV, et al. (2008) Mechanisms of hepatocyte growth factor-mediated and epidermal growth factor-mediated signaling in transdifferentiation of rat hepatocytes to biliary epithelium. Hepatology 47:1702-1713. (Pubitemid 351702752)
33. Long XD, Ma Y, Huang HD, et al. (2008) Polymorphism of XRCC1 and the frequency of mutation in codon 249 of the p53 gene in hepatocellular carcinoma among Guangxi population, China. Mol Carcinog 47:295-300. (Pubitemid 351500155)
34. McCarron SL, Bateman AC, Theaker JM, et al. (2003) EGF +61 gene polymorphism and susceptibility to and prognostic markers in cutaneous malignant melanoma. Int J Cancer 107:673-675. (Pubitemid 37296132)
35. Morton CC, Byers MG, Nakai H, et al. (1986) Human genes for insulin-like growth factors I and II and epidermal growth factor are located on 12q22-q24.1, 11p15, and 4q25-q27, respectively. Cytogenet Cell Genet 41:245-249.
36. Mullhaupt B, Feren A, Fodor E, et al. (1994) Liver expression of epidermal growth factor RNA. Rapid increases in immediateearly phase of liver regeneration. J Biol Chem 269:19667-19670.
37. Shahbazi M, Pravica V, Nasreen N, et al. (2002) Association between functional polymorphism in EGF gene and malignant melanoma. Lancet 359:397-401. (Pubitemid 34158948)
38. Spindler KL, Nielsen JN, Ornskov D, et al. (2007) Epidermal growth factor (EGF) A61G polymorphism and EGF gene expression in normal colon tissue from patients with colorectal cancer. Acta Oncol 46:1113-1117. (Pubitemid 350058877)
39. Tanabe KK, Lemoine A, Finkelstein DM, et al. (2008) Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis. JAMA 299:53-60.
40. Teixeira AL, Ribeiro R, Cardoso D, et al. (2008) Genetic polymorphism in EGF is associated with prostate cancer aggressiveness and progression-free interval in androgen blockade-treated patients. Clin Cancer Res 14:3367-3371.
41. Vautier G, Bomford AB, Portmann BC, et al. (1999) p53 mutations in british patients with hepatocellular carcinoma: clustering in genetic hemochromatosis. Gastroenterology 117:154-160. (Pubitemid 29297632)
42. Vishnoi M, Pandey SN, Modi DR, et al. (2008) Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor beta1-509C>T gene polymorphisms with gallbladder cancer. Hum Immunol 69:360-367.
43. Wu GY, Hasenberg T, Magdeburg R, et al. (2009) Association between EGF, TGF-beta1, VEGF gene polymorphism and colorectal cancer. World J Surg 33:124-129.
44. Yeh CB, Tsai HT, Chen YC, et al. (2010) Genetic polymorphism of CCR2-64I increased the susceptibility of hepatocellular carcinoma. J Surg Oncol 102:264-270.
45. Zhang YM, Cao C, Liang K (2010) Genetic polymorphism of epidermal growth factor 61A>G and cancer risk: a metaanalysis. Cancer Epidemiol 34:150-156.